Yikon Genomics

About Yikon Genomics

Yikon Genomics was founded in 2012, dedicating to the genetic testing in reproductive health and oncology field. We provide reliable medical diagnostic services, as well as reagents and soft wares to our clients around the globe. As for reproductive health products, Yikon Genomics provides complete solutions in analyzing human embryos, endometrium and genetic backgrounds, and has developed a series of assisted reproductive innovation technologies, such as NICS, ERT, PGT-A, PGT-M and so on to help billions of families give birth to healthy babies. Regarding the tumor diagnostics, Yikon Genomics has established a comprehensive system of diagnostic products and interpretative consultation services, spanning from hereditary cancer susceptibility risk assessments in healthy populations to molecular subtyping, chemotherapy, targeted therapy, and immunotherapy guidance for cancer patients, as well as recurrence monitoring and rehabilitation management for postoperative cancer patients.